A typical example is that the lethal consequences of blocking the Ras/Raf/MEK/ERK pathway (e.g., by BRAF inhibitors) can be compromised by the activation of the PI3K/AKT pathway in tumor cells (20, 21). This evidence concerns the gene MAP2K7 and neoplasm.